- Home
- MOMO vs NEO Comparison
MOMO vs NEO Comparison
Compare MOMO & NEO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | MOMO | NEO |
|---|---|---|
| Founded | 2011 | 2001 |
| Country | China | United States |
| Employees | N/A | N/A |
| Industry | Computer Software: Prepackaged Software | Precision Instruments |
| Sector | Technology | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.1B | 1.2B |
| IPO Year | 2014 | 1999 |
Fundamental Metrics
Financial Performance| Metric | MOMO | NEO |
|---|---|---|
| Price | $6.67 | $11.90 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 1 | 9 |
| Target Price | ★ $13.00 | $11.38 |
| AVG Volume (30 Days) | 1.2M | ★ 1.7M |
| Earning Date | 12-10-2025 | 10-28-2025 |
| Dividend Yield | ★ 4.51% | N/A |
| EPS Growth | N/A | ★ N/A |
| EPS | ★ 0.60 | N/A |
| Revenue | ★ $1,464,746,462.00 | $709,162,000.00 |
| Revenue This Year | $0.30 | $10.90 |
| Revenue Next Year | $3.19 | $9.88 |
| P/E Ratio | $11.00 | ★ N/A |
| Revenue Growth | N/A | ★ 10.10 |
| 52 Week Low | $5.12 | $4.72 |
| 52 Week High | $9.22 | $19.12 |
Technical Indicators
Market Signals| Indicator | MOMO | NEO |
|---|---|---|
| Relative Strength Index (RSI) | 43.49 | 57.42 |
| Support Level | $6.42 | $11.46 |
| Resistance Level | $6.71 | $12.19 |
| Average True Range (ATR) | 0.20 | 0.37 |
| MACD | -0.03 | -0.11 |
| Stochastic Oscillator | 36.69 | 38.13 |
Price Performance
Historical ComparisonAbout MOMO Hello Group Inc.
Hello Group Inc provides mobile-based social networking services. It enables users to establish and expand social relationships based on location and interests. Its platform includes the Momo mobile application and a variety of related features, functionalities, tools, and services that it provides to users, customers, and platform partners. The company derives its revenue from live video services, value-added services, mobile marketing services, mobile games, and other services. It operates in three segments: Momo's service lines, Tantan's service lines, and QOOL's service lines, out of which Momo's service lines segment derives the majority of revenue.
About NEO NeoGenomics Inc.
NeoGenomics Inc provides oncology diagnostic testing and consultative services which include technical laboratory services and professional interpretation of laboratory test results by licensed physicians or molecular experts in pathology and oncology. It operates a network of cancer-focused testing laboratories in the United States and the United Kingdom. The company operates in a single segment and derives revenue from clients by providing clinical cancer testing, interpretation, and consultative services, molecular and NGS testing, comprehensive technical and professional services offerings, clinical trials and research, validation laboratory services, and oncology data solutions.